Follow the Coagulation Cascade

to Chocolate Town USA POC Meeting

March 10, 2009

Agenda I RSVP I Directions I Speakers

Penn State Milton S. Hershey Medical Center

500 University Drive, Hershey, PA 17033 • 717-531-0003 ext#283256


Hosts: Carrie Bell & Tom Stipe


We thank Roche and Abbott Point of Care for Providing Educational Support


Our PACE Credit sponsor Nova Biomedical Corporation



Continental Breakfast & Sign-in


Welcome & Announcements


“Heparin Monitoring”

Presenter: Thomas Nifong MD




“Overview of a Pharmacist-based Anticoagulation Clinic”


Beth Bittner, B.S. Pharm, RPh

Frank Herrmann, B.S. Pharm, RPh

Paul Kocis, B.S. Pharm, Pharm.D., RPh

Penn State Hershey Medical Center Anticoagulation Clinic

Karen Runkel, CPC

Penn State Hershey Medical Center Department of Pharmacy



Please be sure to visit all of our vendors who have graciously supported our meeting today!


“Patient Safety”

Debra Barnette Pharm.D.


Business Meeting

Please join us for our regular meeting, plus a special presentation by Marcy Anderson on the POC Specialist Certificate Program from AACC.

RSVP by February 27th


Reply by Email: OR by Fax at: 717-228-2986 (Attn: Noreen Berkheiser). For more information contact: Noreen Berkheiser @ 717-228-2945 x203. There is a $10.00 meeting registration fee for all non-KEYPOCC members.

Directions & Registration


Directions to Conference Center (once you are on campus)

Enter the main entrance of the medical center at the intersection of Route

322 and University Drive. At the first stop sign, turn right onto Campus

Drive. Follow Campus Drive until you see the sign on your right for the

University Fitness and Conference Center. Turn right and look for signs for

Fitness and Conference Center parking.


Parking is in the University Fitness and Conference Center parking

lot to the front and to the left of the facility. There are signs posted

that the lot is for University Fitness and Conference Center only.



Thomas Nifong MD, Associate Professor of Pathology at the Penn State Hershey Medical Center. His clinical roles include Medical Director of the Hematology and Thrombosis Laboratory and Staff Physician in Clinical Pathology and Apheresis. Today Dr. Nifong will focus on Heparin Monitoring. Normal hemostasis is controlled by a balanced interaction between vascular, platelet, and coagulation systems. When this balance is perturbed it can

result in thrombosis or bleeding. Heparin is often used as an anticoagulant to prevent thrombosis in patients undergoing surgical procedures. This presentation will emphasize heparin use and monitoring to decrease complications of both thrombosis and bleeding.


Beth Bittner, B.S. Pharm, RPh, Frank Herrmann, B.S. Pharm,RPh and Paul Kocis, B.S. Pharm, Pharm.D., RPh are all staff members of the Penn State Hershey Medical Center Anticoagulation Clinic.


Karen Runkel is a Certified Professional Coder with the Department of Pharmacy. Participants will gain an understanding of the benefits of a pharmacist-based anticoagulation clinic versus routine medical care with a dramatic presentation. Participants will also gain understanding of the value

of point-of-care anticoagulation monitoring. A review of the history

of the Penn State Hershey Medical Center Anticoagulation Clinic with its challenges and successes will be undertaken. Participants will also gain an understanding of basic coding and reimbursement guide lines as they pertain to Medicare and Third Party payers.


Debra Barnette Pharm.D. is from Wake Forest University Baptist Medical Center, Winston-Salem N.C. and is a talented member of Roche’s Speakers Program will present on patient safety with a concentration on the National Patient Safety goals as they relate to anti-coagulation therapy. There have been a lot of changes in the last 12 month regarding anti-coagulation management. The Joint Commission 3E guidelines were given and many institutions are in the process of resolving these issues. Standardization is the key for the future. The goal is to reduce the likelihood of patient harm

associated with the use of anti-coagulation therapies.


Back to top

Last updated: 09/16/2009 • Questions or corrections: My Point of